Accessibility Menu
 
International Stem Cell logo

International Stem Cell

(OTC) ISCO

Current Price$0.14
Market Cap$1.09M
Since IPO (2007)-100%
5 Year-83%
1 Year+24%
1 Month-20%

International Stem Cell Financials at a Glance

Market Cap

$1.09M

Revenue (TTM)

$9.39M

Net Income (TTM)

$59.00K

EPS (TTM)

$-0.02

P/E Ratio

-7.27

Dividend

$0.00

Beta (Volatility)

0.37 (Low)

Price

$0.14

Volume

15,012

Open

$0.15

Previous Close

$0.14

Daily Range

$0.14 - $0.17

52-Week Range

$0.11 - $0.27

ISCO News

No articles available.

ISCO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About International Stem Cell

Industry

Biotechnology

Employees

32

CEO

Andrey Semechkin, PhD

Headquarters

San Diego, CA 92131, US

ISCO Financials

Key Financial Metrics (TTM)

Gross Margin

58%

Operating Margin

1%

Net Income Margin

-1%

Return on Equity

-38%

Return on Capital

15%

Return on Assets

-1%

Earnings Yield

-13.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.09M

Shares Outstanding

8.00M

Volume

15.01K

Short Interest

0.00%

Avg. Volume

6.91K

Financials (TTM)

Gross Profit

$5.32M

Operating Income

$68.00K

EBITDA

$142.00K

Operating Cash Flow

$13.00K

Capital Expenditure

$166.00K

Free Cash Flow

$153.00K

Cash & ST Invst.

$1.23M

Total Debt

$3.84M

International Stem Cell Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$2.37M

+8.7%

Gross Profit

$1.32M

+9.6%

Gross Margin

55.76%

N/A

Market Cap

$1.09M

N/A

Market Cap/Employee

$34.02K

N/A

Employees

32

N/A

Net Income

$57.00K

+145.6%

EBITDA

$114.00K

+408.1%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$2.93M

-14.0%

Accounts Receivable

$1.07M

+56.9%

Inventory

$1.59M

+15.0%

Long Term Debt

$206.00K

+1.5%

Short Term Debt

$3.69M

+0.4%

Return on Assets

-1.12%

N/A

Return on Invested Capital

15.47%

N/A

Free Cash Flow

$46.00K

-79.1%

Operating Cash Flow

$49.00K

-80.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EVFMEvofem Biosciences, Inc.
$0.01-5.88%
BIORBiora Therapeutics, Inc.
$0.22+0.00%
UNBXUnity Biotechnology, Inc.
$0.06+0.00%
BMNDFBiomind Labs Inc.
$0.01-57.03%

Trending Stocks

Symbol / CompanyPricePrice Chg
CMCSAComcast
$29.02+0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
ANNAAleAnna
$7.07+0.87%

Questions About ISCO

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.